ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

210
Analysis
Health Care • India
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
•05 Nov 2018 22:59

EM Strategy: Brazil Breaking Out, EM Energy Remains Attractive

While the MSCI EM index remains in a well-defined downtrend, and we continue to recommend selectivity, we highlight several investable themes and...

Logo
629 Views
Share
bearish•Cross Asset Strategy
•01 Apr 2025 09:51

Asian Alpha Hedge Fund (AAHF): INTRODUCTION

Asian Alpha Hedge Fund (AAHF) returned 32% in the first quarter of 2025.  The fund outperformed the MSCI All Country Asia Pacific index by 28%. ...

Logo
147 Views
Share
•01 Oct 2018 05:35

EM Strategy: Russia and Thailand Bullishly Inflecting; Pullback Opportunity in India

This report highlights actionable themes across the EM universe, including: bullish inflections in the Russian and Thai markets, and a pullback...

Logo
563 Views
Share
•06 Aug 2018 17:11

Para IV Winners and Losers - July 2018

This month’s Para IV developments suggest that there is likely to be benefit to Par Pharma, Dr. Reddy'S Laboratories (DRRD IN) & Amneal...

Logo
440 Views
Share
bearish•Larsen & Toubro
•12 Sep 2017 17:12

India: After Maruti Suzuki and Reliance Industries, Will Larsen & Toubro Outperform the Markets Now?

It has been a struggle to find money making ideas in Indian large cap spaceIndian markets have done well in CY17 with BSE SENSEX delivering...

Logo
289 Views
Share
x